Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Times Denmark.
In Vitro Diagnostics Market Size on Track for a USD 123.45 Billion Momentum by 2034, says Healthcare Specialist
Ottawa, April 11, 2025 (GLOBE NEWSWIRE) -- The global in vitro diagnostics market size was valued at USD 81.47 billion in 2024 and is predicted to hit around USD 123.45 billion by 2034, a study published by Towards Healthcare a sister firm of...
Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer
Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials through global regulatory approvals, and establishing new standards of care in gynecological oncology over the past...
Pharmaceutical Logistics Market Size Expected to Reach $191.1 Mn by 2034
Ottawa, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The global pharmaceutical logistics market size was valued at USD 111.45 million in 2024 and is predicted to hit around USD 181.07 million by 2033, a study published by Towards Healthcare a sister firm of...
A Novo Nordisk - Broad collaboration is connecting Denmark-based and Broad researchers
When Maddie Murphy, a computational associate at the Broad Institute of MIT and Harvard, first learned she’d have the opportunity to pursue her research in Copenhagen, she envisioned a two- or three-week visit. Then her supervisor, Ray Jones, told...
Owner: Broad institute (Non-profit)
Building bridges between Denmark-based and Broad researchers
When Maddie Murphy, a computational associate at the Broad Institute of MIT and Harvard, first learned she’d have the opportunity to pursue her research in Copenhagen, she envisioned a two- or three-week visit. Then her supervisor, Ray Jones, told...
Owner: Broad institute (Non-profit)
Global Biotechnology Market Size to Reach USD 5,036.46 Bn by 2034, Growing at 12.5% CAGR, Says Healthcare Experts
Ottawa, April 10, 2025 (GLOBE NEWSWIRE) -- The global biotechnology market size was valued at USD 1,550.96 billion in 2024 and is predicted to hit around USD 5036.46 billion by 2034, a study published by Towards Healthcare a sister firm of...
Respiratory & Anaesthesia Disposable Market 2024–2032 | Size & Forecast
Respiratory and Anaesthesia Disposable Market revenue is expected to grow at a CAGR of 5.6% from 2025 to 2032, reaching nearly USD 77.94 billion. SACRAMENTO, CA, UNITED STATES, October 15, 2025 /EINPresswire.com/ -- Respiratory and anaesthesia...
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share Advances Akero’s Mission of Bringing Novel Therapies to Patients with High Unmet Medical Needs SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics,...
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025
Company announcement – No. 8 / 2025 Total number of shares and voting rights in Zealand Pharma as of March 31, 2025 Copenhagen, Denmark, March 31, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Carolinas MGMA Hosts Fall Conference, Celebrates Collaboration Across the Carolinas
Carolinas MGMA welcomed healthcare leaders from across the region to its 2025 Fall Conference, held Sept. 17–19 at the Hilton Myrtle Beach Resort. MYRTLE BEACH, SC, UNITED STATES, October 6, 2025 /EINPresswire.com/ -- Carolinas Medical Group...
Trust Stamp Denmark Joins Mastercard Lighthouse MASSIV Program
COPENHAGEN, April 02, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ has been selected as one of the five companies to join the competitive Mastercard Lighthouse MASSIV 2025 program. The initiative...
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
THE WOODLANDS, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin...
Premier Promotes Nova Scotia in Denmark
CANADA, April 4 - Premier Tim Houston will leave for Copenhagen, Denmark, Saturday, April 5, on a provincial trade mission. During the five-day mission, the Premier will meet with new and existing partners to strengthen relationships. Meetings...
Owner: Canadian Government
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the...
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the...
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Company announcement – No. 6 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on...
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
Press release – No. 4 / 2025 Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity Initiated in December 2024, the Phase 2b ZUPREME-1 trial is designed to evaluate...
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a...
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 5 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology...